GluSense injectable glucose sensor receives investment from JDRF T1D Fund

March 10, 2017
GluSense is developing a long-lasting injectable glucose sensor for treating Type 1 diabetes.

Medical device maker GluSense (Rehovot, Israel), which is developing a long-lasting injectable glucose sensor for treating Type 1 diabetes, has received an investment from the JDRF T1D Fund, a venture philanthropy fund exclusively devoted to finding and funding early-stage Type 1 diabetes commercial programs.

Related: Light-driven biometric watches monitor glucose, pulse noninvasively

GluSense's Glyde CGM is a miniature long-term injectable glucose sensor. It is injected under the skin and expected to last for one year, providing continuous, accurate glucose measurements wirelessly to a convenient wearable device such as a watch. The injection of the device is minimally invasive and can be performed in a clinic using only local anesthesia. The T1D Fund's investment will be used to bring the device closer to the first in-human clinical trial, a key step in the commercialization process.

The device's technology uses a proprietary fluorescent glucose-sensitive biosensor that ensures accurate glucose measurement across the full physiological range, with enhanced accuracy at the medically important hypo-glucose range. The development ensures that the biosensor level in the implant is maintained stable over the long term using engineered live cells that constantly replenish the biosensor in the implant. The stable biosensor level enables calibration frequency to be significantly reduced, freeing users from the daily hassle of multiple calibration finger pricks.

GluSense is part of the Rainbow Medical innovation firm (Herzeliya Pituach, Israel), which seeds and grows companies developing breakthrough medical devices.

For more information, please visit and

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)

Sponsored Recommendations

Request a quote: Micro 3D Printed Part or microArch micro-precision 3D printers

April 11, 2024
See the results for yourself! We'll print a benchmark part so that you can assess our quality. Just send us your file and we'll get to work.

Request a free Micro 3D Printed sample part

April 11, 2024
The best way to understand the part quality we can achieve is by seeing it first-hand. Request a free 3D printed high-precision sample part.

How to Tune Servo Systems: The Basics

April 10, 2024
Learn how to tune a servo system using frequency-based tools to meet system specifications by watching our webinar!

Precision Motion Control for Sample Manipulation in Ultra-High Resolution Tomography

April 10, 2024
Learn the critical items that designers and engineers must consider when attempting to achieve reliable ultra-high resolution tomography results here!

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!